Pimavanserin
ACP-103-063
Approved small_molecule completed
Quick answer
Pimavanserin for Parkinson Disease Psychosis is a Approved program (small_molecule) at ACADIA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ACADIA PHARMACEUTICALS INC
- Indication
- Parkinson Disease Psychosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed